NSETrading Window26 Jun 2026 · 26 Jun 2026, 11:42 am
Trading Window
Gufic Biosciences Limited · GUFICBIO
✦ AI SummaryResults
Gufic Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in securities of the Company shall remain closed for all the Designated Persons and their immediate relatives from Wednesday, July 01, 2026 till 48 hours after the declaration of Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact7/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gufic Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
GUFIC_26062026114106_FinalIntimationTW.pdf
View document text
176/LG/SE/JUNE/2026/GBSL
June 26, 2026
To, To,
National Stock Exchange of India Limited, BSE Limited,
Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Dalal Street,
Bandra (E), Mumbai – 400 051 Mumbai – 400 001
Scrip Symbol: GUFICBIO Scrip Code: 509079
Subject: Intimation of closure of Trading Window
Dear Sir/Madam,
This is to inform that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations,
2015, as amended from time to time and the Company’s Code of Conduct framed under the said
provisions, the Trading Window for dealing in securities of the Company shall remain closed for all the
Designated Persons and their immediate relatives from Wednesday, July 01, 2026 till 48 hours after
the declaration of Unaudited Financial Results (Standalone and Consolidated) of the Company for the
quarter ended June 30, 2026.
The date of meeting of the Board of Directors to consider and approve the Unaudited Financial Results
(Standalone and Consolidated) of the Company for the quarter ended June 30, 2026 will be intimated
in due course.
Kindly take the same on record.
Thanking you,
Yours faithfully,
For Gufic Biosciences Limited
Ami Shah
Company Secretary & Compliance Officer
Membership No. A39579